Freddie Mac announced the successful completion of its tender offer to purchase approximately $1.1 billion in Structured Agency Credit Risk (STACR) notes across five classes. The offer, which expired on October 30, 2026, saw nearly full acceptance from note holders, with settlement expected on November 3, 2026. This transaction supports Freddie Mac's ongoing strategy to transfer mortgage credit risk to private investors, reducing taxpayer exposure. The tender was managed by Wells Fargo Securities, Cantor Fitzgerald & Co., and CastleOak Securities.
Freddie Mac's tender offer for STACR notes provides context for financial markets. For readers following Financials, here is Pluang's market snapshot as of Nov 02, 2026 21:03 WIB: out of 142 priced US Financials stocks, 88 rose and 25 fell. Notable movers include Lemonade Inc at USD 43.82 (+2.05%), Riot Platforms Inc at USD 13.07 (+2.03%), and CleanSpark Inc at USD 7.81 (+2.02%).
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
